Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1291

1.

How we treat glioblastoma.

Weller M, Le Rhun E, Preusser M, Tonn JC, Roth P.

ESMO Open. 2019 Jun 17;4(Suppl 2):e000520. doi: 10.1136/esmoopen-2019-000520. eCollection 2019. Review.

2.

Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma.

Wirsching HG, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino PJ, Amankulor N, Campbell JS, McFerrin L, Pattwell SS, Ene C, Hicks A, Ball M, Yan J, Zhang J, Kumasaka D, Pierce RH, Weller M, Finer M, Quéva C, Glorioso JC, Houghton AM, Holland EC.

JCI Insight. 2019 Jul 11;4(13). pii: 128217. doi: 10.1172/jci.insight.128217. eCollection 2019 Jul 11.

3.

Long-term complications and reconstruction failures in previously radiated breast cancer patients receiving salvage mastectomy with autologous reconstruction or tissue expander/implant-based reconstruction.

Manyam BV, Shah C, Woody NM, Reddy CA, Weller MA, Juloori A, Naik M, Valente S, Grobmyer S, Durand P, Djohan R, Tendulkar RD.

Breast J. 2019 Jul 1. doi: 10.1111/tbj.13428. [Epub ahead of print]

PMID:
31264293
4.

Long-term Outcomes After Autologous or Tissue Expander/Implant Based Breast Reconstruction and Post-Mastectomy Radiation for Breast Cancer.

Manyam BV, Shah C, Woody NM, Reddy CA, Weller MA, Juloori A, Naik M, Valente S, Grobmyer S, Durand P, Djohan R, Tendulkar RD.

Pract Radiat Oncol. 2019 Jun 22. pii: S1879-8500(19)30179-1. doi: 10.1016/j.prro.2019.06.008. [Epub ahead of print]

PMID:
31238166
5.

How we treat patients with leptomeningeal metastases.

Le Rhun E, Preusser M, van den Bent M, Andratschke N, Weller M.

ESMO Open. 2019 May 21;4(Suppl 2):e000507. doi: 10.1136/esmoopen-2019-000507. eCollection 2019. Review.

6.

Data Sets for the Reporting of Tumors of the Central Nervous System.

Louis DN, Wesseling P, Brandner S, Brat DJ, Ellison DW, Giangaspero F, Hattab EM, Hawkins C, Judge MJ, Kleinschmidt-DeMasters B, Komori T, McLean C, Paulus W, Perry A, Reifenberger G, Weller M, Rous B.

Arch Pathol Lab Med. 2019 Jun 20. doi: 10.5858/arpa.2018-0565-OA. [Epub ahead of print]

PMID:
31219344
7.

The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials.

Coomans M, Dirven L, K Aaronson N, Baumert BG, van den Bent M, Bottomley A, Brandes AA, Chinot O, Coens C, Gorlia T, Herrlinger U, Keime-Guibert F, Malmström A, Martinelli F, Stupp R, Talacchi A, Weller M, Wick W, Reijneveld JC, Taphoorn MJB; EORTC Quality of Life Group and the EORTC Brain Tumor Group.

Eur J Cancer. 2019 Jul;116:190-198. doi: 10.1016/j.ejca.2019.05.012. Epub 2019 Jun 13.

PMID:
31203194
8.

Barriers to Accrual and Enrollment in Brain Tumor Trials.

Lee EQ, Chukwueke UN, Hervey-Jumper SL, de Groot JF, Leone JP, Armstrong TS, Chang SM, Arons D, Oliver K, Verble K, Musella A, Willmarth N, Alexander BM, Bates A, Doherty L, Galanis E, Gaffey S, Halkin T, Friday BE, Fouladi M, Lin NU, Macdonald D, Mehta MP, Penas-Prado M, Vogelbaum MA, Sahebjam S, Sandak D, van den Bent M, Weller M, Reardon DA, Wen PY.

Neuro Oncol. 2019 Jun 7. pii: noz104. doi: 10.1093/neuonc/noz104. [Epub ahead of print]

PMID:
31175826
9.

DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management.

Nassiri F, Mamatjan Y, Suppiah S, Badhiwala JH, Mansouri S, Karimi S, Saarela O, Poisson L, Gepfner-Tuma I, Schittenhelm J, Ng HK, Noushmehr H, Harter P, Baumgarten P, Weller M, Preusser M, Herold-Mende C, Tatagiba M, Tabatabai G, Sahm F, von Deimling A, Zadeh G, Aldape KD; International Consortium on Meningiomas .

Neuro Oncol. 2019 Jun 3. pii: noz061. doi: 10.1093/neuonc/noz061. [Epub ahead of print]

PMID:
31158293
10.

Defining EGFR amplification status for clinical trial inclusion.

French PJ, Eoli M, Sepulveda JM, de Heer I, Kros JM, Walenkamp A, Frenel JS, Franceschi E, Clement PM, Weller M, Ansell P, Looman J, Bain E, Morfouace M, Gorlia T, van den Bent M.

Neuro Oncol. 2019 May 24. pii: noz096. doi: 10.1093/neuonc/noz096. [Epub ahead of print]

PMID:
31125418
11.

Equal Footing of Thermal Expansion and Electron-Phonon Interaction in the Temperature Dependence of Lead Halide Perovskite Band Gaps.

Francisco-López A, Charles B, Weber OJ, Alonso MI, Garriga M, Campoy-Quiles M, Weller MT, Goñi AR.

J Phys Chem Lett. 2019 Jun 6;10(11):2971-2977. doi: 10.1021/acs.jpclett.9b00876. Epub 2019 May 22.

PMID:
31091105
12.

Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study.

Nowosielski M, Gorlia T, Bromberg JEC, Sahm F, Harting I, Kickingereder P, Brandes AA, Taphoorn MJB, Taal W, Domont J, Idbaih A, Campone M, Clement PM, Weller M, Fabbro M, Le Rhun E, Platten M, Golfinopoulos V, van den Bent MJ, Bendszus M, Wick W.

Neurology. 2019 Jun 11;92(24):e2754-e2763. doi: 10.1212/WNL.0000000000007643. Epub 2019 May 10.

PMID:
31076534
13.

[Challenges and future perspectives in neuro-oncology].

Tabatabai G, Weller M.

Nervenarzt. 2019 Jun;90(6):594-600. doi: 10.1007/s00115-019-0716-4. Review. German.

PMID:
31073670
14.

Mutational patterns and regulatory networks in epigenetic subgroups of meningioma.

Paramasivam N, Hübschmann D, Toprak UH, Ishaque N, Neidert M, Schrimpf D, Stichel D, Reuss D, Sievers P, Reinhardt A, Wefers AK, Jones DTW, Gu Z, Werner J, Uhrig S, Wirsching HG, Schick M, Bewerunge-Hudler M, Beck K, Brehmer S, Urbschat S, Seiz-Rosenhagen M, Hänggi D, Herold-Mende C, Ketter R, Eils R, Ram Z, Pfister SM, Wick W, Weller M, Grossmann R, von Deimling A, Schlesner M, Sahm F.

Acta Neuropathol. 2019 May 8. doi: 10.1007/s00401-019-02008-w. [Epub ahead of print]

PMID:
31069492
15.

Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization.

Le Joncour V, Filppu P, Hyvönen M, Holopainen M, Turunen SP, Sihto H, Burghardt I, Joensuu H, Tynninen O, Jääskeläinen J, Weller M, Lehti K, Käkelä R, Laakkonen P.

EMBO Mol Med. 2019 Jun;11(6). pii: e9034. doi: 10.15252/emmm.201809034.

16.

Efficient Screening of Combinatorial Peptide Libraries by Spatially Ordered Beads Immobilized on Conventional Glass Slides.

Schwaar T, Lettow M, Remmler D, Börner HG, Weller MG.

High Throughput. 2019 Apr 30;8(2). pii: E11. doi: 10.3390/ht8020011.

17.

Differential Impact of Education Level, Occupation and Marital Status on Performance of the Papanicolaou Test among Women from Various Regions in Brazil

Açucena Vieira Alves S, Schiaveto de Souza A, Weller M, Pires Batiston A.

Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1037-1044.

18.

DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.

Binder H, Willscher E, Loeffler-Wirth H, Hopp L, Jones DTW, Pfister SM, Kreuz M, Gramatzki D, Fortenbacher E, Hentschel B, Tatagiba M, Herrlinger U, Vatter H, Matschke J, Westphal M, Krex D, Schackert G, Tonn JC, Schlegel U, Steiger HJ, Wick W, Weber RG, Weller M, Loeffler M.

Acta Neuropathol Commun. 2019 Apr 25;7(1):59. doi: 10.1186/s40478-019-0704-8.

19.

Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysis.

Seliger C, Genbrugge E, Gorlia T, Chinot O, Stupp R, Nabors B, Weller M, Hau P; EORTC Brain Tumor Group.

Int J Cancer. 2019 Apr 13. doi: 10.1002/ijc.32337. [Epub ahead of print]

PMID:
30980539
20.

Laser-Induced Microplasma as an Ambient Ionization Approach for the Mass-Spectrometric Analysis of Liquid Samples.

Bierstedt A, You Y, van Wasen S, Bosc-Bierne G, Weller M, Riedel J.

Anal Chem. 2019 May 7;91(9):5922-5928. doi: 10.1021/acs.analchem.9b00329. Epub 2019 Apr 11.

PMID:
30933486
21.

Patient experiences in behavioral health integrated primary care settings: the role of stigma in shaping patient outcomes over time.

Royal Kenton N, Broffman L, Jones K, Albrecht Mcmenamin K, Weller M, Brown K, Currier J, Wright B.

Psychol Health Med. 2019 Mar 29:1-16. doi: 10.1080/13548506.2019.1595685. [Epub ahead of print]

PMID:
30924365
22.

Evolutionary Trajectories of IDHWT Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial Diagnosis.

Körber V, Yang J, Barah P, Wu Y, Stichel D, Gu Z, Fletcher MNC, Jones D, Hentschel B, Lamszus K, Tonn JC, Schackert G, Sabel M, Felsberg J, Zacher A, Kaulich K, Hübschmann D, Herold-Mende C, von Deimling A, Weller M, Radlwimmer B, Schlesner M, Reifenberger G, Höfer T, Lichter P.

Cancer Cell. 2019 Apr 15;35(4):692-704.e12. doi: 10.1016/j.ccell.2019.02.007. Epub 2019 Mar 21.

PMID:
30905762
23.

Enantioselective fragmentation of an achiral molecule in a strong laser field.

Fehre K, Eckart S, Kunitski M, Pitzer M, Zeller S, Janke C, Trabert D, Rist J, Weller M, Hartung A, Schmidt LPH, Jahnke T, Berger R, Dörner R, Schöffler MS.

Sci Adv. 2019 Mar 8;5(3):eaau7923. doi: 10.1126/sciadv.aau7923. eCollection 2019 Mar.

24.

Immunotherapy for glioblastoma: quo vadis?

Weller M, Le Rhun E.

Nat Rev Clin Oncol. 2019 Jul;16(7):405-406. doi: 10.1038/s41571-019-0195-3. No abstract available.

PMID:
30867572
25.

CHD7 promotes glioblastoma cell motility and invasiveness through transcriptional modulation of an invasion signature.

Machado RAC, Schneider H, DeOcesano-Pereira C, Lichtenstein F, Andrade F, Fujita A, Trombetta-Lima M, Weller M, Bowman-Colin C, Sogayar MC.

Sci Rep. 2019 Mar 8;9(1):3952. doi: 10.1038/s41598-019-39564-w.

26.

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.

Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, Kortmann RD, Krex D, Grauer O, Goldbrunner R, Schnell O, Bähr O, Uhl M, Seidel C, Tabatabai G, Kowalski T, Ringel F, Schmidt-Graf F, Suchorska B, Brehmer S, Weyerbrock A, Renovanz M, Bullinger L, Galldiks N, Vajkoczy P, Misch M, Vatter H, Stuplich M, Schäfer N, Kebir S, Weller J, Schaub C, Stummer W, Tonn JC, Simon M, Keil VC, Nelles M, Urbach H, Coenen M, Wick W, Weller M, Fimmers R, Schmid M, Hattingen E, Pietsch T, Coch C, Glas M; Neurooncology Working Group of the German Cancer Society.

Lancet. 2019 Feb 16;393(10172):678-688. doi: 10.1016/S0140-6736(18)31791-4. Epub 2019 Feb 14.

PMID:
30782343
27.

Ten-Year Outcomes of Moderately Hypofractionated (70 Gy in 28 fractions) Intensity Modulated Radiation Therapy for Localized Prostate Cancer.

Abu-Gheida I, Reddy CA, Kotecha R, Weller MA, Shah C, Kupelian PA, Mian O, Ciezki JP, Stephans KL, Tendulkar RD.

Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):325-333. doi: 10.1016/j.ijrobp.2019.01.091. Epub 2019 Feb 2.

PMID:
30721720
28.

The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposal.

Le Rhun E, Devos P, Boulanger T, Smits M, Brandsma D, Rudà R, Furtner J, Hempel JM, Postma TJ, Roth P, Snijders TJ, Winkler F, Winklhofer S, Castellano A, Hattingen E, Capellades J, Gorlia T, Van den Bent M, Wen PY, Bendszus M, Weller M; European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group (BTG) Central Nervous System (CNS) Metastases Committee and the EORTC BTG Imaging Committee.

Neuro Oncol. 2019 May 6;21(5):648-658. doi: 10.1093/neuonc/noz024.

PMID:
30715514
29.

Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications.

Boire A, Brandsma D, Brastianos PK, Le Rhun E, Ahluwalia M, Junck L, Glantz M, Groves MD, Lee EQ, Lin N, Raizer J, Rudà R, Weller M, Van den Bent MJ, Vogelbaum MA, Chang S, Wen PY, Soffietti R.

Neuro Oncol. 2019 May 6;21(5):571-584. doi: 10.1093/neuonc/noz012.

30.

PET imaging in patients with brain metastasis-report of the RANO/PET group.

Galldiks N, Langen KJ, Albert NL, Chamberlain M, Soffietti R, Kim MM, Law I, Le Rhun E, Chang S, Schwarting J, Combs SE, Preusser M, Forsyth P, Pope W, Weller M, Tonn JC.

Neuro Oncol. 2019 May 6;21(5):585-595. doi: 10.1093/neuonc/noz003.

PMID:
30615138
31.

Breakdown of the Spectator Concept in Low-Electron-Energy Resonant Decay Processes.

Mhamdi A, Rist J, Aslitürk D, Weller M, Melzer N, Trabert D, Kircher M, Vela-Pérez I, Siebert J, Eckart S, Grundmann S, Kastirke G, Waitz M, Khan A, Schöffler MS, Trinter F, Dörner R, Jahnke T, Demekhin PV.

Phys Rev Lett. 2018 Dec 14;121(24):243002. doi: 10.1103/PhysRevLett.121.243002.

PMID:
30608769
32.

RNA sequencing differential gene expression analysis of isolated perfused bovine udders experimentally inoculated with Streptococcus agalactiae.

Sbardella AP, Weller MMDCA, Fonseca I, Stafuzza NB, Bernardes PA, E Silva FF, da Silva MVGB, Martins MF, Munari DP.

J Dairy Sci. 2019 Feb;102(2):1761-1767. doi: 10.3168/jds.2018-15516. Epub 2018 Dec 26.

PMID:
30594374
33.

Closed-loop cavitation control for focused ultrasound-mediated blood-brain barrier opening by long-circulating microbubbles.

Çavuşoğlu M, Zhang J, Ielacqua GD, Pellegrini G, Signorell RD, Papachristodoulou A, Brambilla D, Roth P, Weller M, Rudin M, Martin E, Leroux JC, Werner B.

Phys Med Biol. 2019 Feb 11;64(4):045012. doi: 10.1088/1361-6560/aafaa5.

PMID:
30577029
34.

Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases.

Seoane J, De Mattos-Arruda L, Le Rhun E, Bardelli A, Weller M.

Ann Oncol. 2019 Feb 1;30(2):211-218. doi: 10.1093/annonc/mdy544.

PMID:
30576421
35.

Beyond the headlines: Fetal movement awareness is an important stillbirth prevention strategy.

Flenady V, Ellwood D, Bradford B, Coory M, Middleton P, Gardener G, Radestad I, Homer C, Davies-Tuck M, Forster D, Gordon A, Groom K, Crowther C, Walker S, Foord C, Warland J, Murphy M, Said J, Boyle F, O'Donoghue K, Cronin R, Sexton J, Weller M, McCowan L.

Women Birth. 2019 Feb;32(1):1-2. doi: 10.1016/j.wombi.2018.12.001. Epub 2018 Dec 15. No abstract available.

PMID:
30563769
36.

Profound, durable and MGMT-independent sensitivity of glioblastoma cells to cyclin-dependent kinase inhibition.

Le Rhun E, von Achenbach C, Lohmann B, Silginer M, Schneider H, Meetze K, Szabo E, Weller M.

Int J Cancer. 2019 Jul 1;145(1):242-253. doi: 10.1002/ijc.32069. Epub 2019 Jan 12.

PMID:
30549269
37.

MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy.

Krell A, Wolter M, Stojcheva N, Hertler C, Liesenberg F, Zapatka M, Weller M, Malzkorn B, Reifenberger G.

Neuropathol Appl Neurobiol. 2019 Aug;45(5):441-458. doi: 10.1111/nan.12532. Epub 2019 Feb 19.

PMID:
30548945
38.

Chemotherapy sensitization of glioblastoma by focused ultrasound-mediated delivery of therapeutic liposomes.

Papachristodoulou A, Signorell RD, Werner B, Brambilla D, Luciani P, Cavusoglu M, Grandjean J, Silginer M, Rudin M, Martin E, Weller M, Roth P, Leroux JC.

J Control Release. 2019 Feb 10;295:130-139. doi: 10.1016/j.jconrel.2018.12.009. Epub 2018 Dec 8.

PMID:
30537486
39.

Mobile Workflow in Computed Tomography of the Chest.

Wetzl M, Weller M, Heiss R, Schrüfer E, Wuest W, Thierfelder C, Lerch D, Cavallaro A, Amarteifio P, Uder M, May MS.

J Med Syst. 2018 Dec 10;43(1):14. doi: 10.1007/s10916-018-1131-2.

40.

Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0.

Law I, Albert NL, Arbizu J, Boellaard R, Drzezga A, Galldiks N, la Fougère C, Langen KJ, Lopci E, Lowe V, McConathy J, Quick HH, Sattler B, Schuster DM, Tonn JC, Weller M.

Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):540-557. doi: 10.1007/s00259-018-4207-9. Epub 2018 Dec 5.

41.

Pseudoprogression: fact or wishful thinking in neuro-oncology?

Reardon DA, Weller M.

Lancet Oncol. 2018 Dec;19(12):1561-1563. doi: 10.1016/S1470-2045(18)30654-5. No abstract available.

PMID:
30507413
42.

MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials.

Hegi ME, Genbrugge E, Gorlia T, Stupp R, Gilbert MR, Chinot OL, Nabors LB, Jones G, Van Criekinge W, Straub J, Weller M.

Clin Cancer Res. 2019 Mar 15;25(6):1809-1816. doi: 10.1158/1078-0432.CCR-18-3181. Epub 2018 Dec 4.

PMID:
30514777
43.

Digging into the Sequential Space of Thiolactone Precision Polymers: A Combinatorial Strategy to Identify Functional Domains.

Celasun S, Remmler D, Schwaar T, Weller MG, Du Prez F, Börner HG.

Angew Chem Int Ed Engl. 2019 Feb 11;58(7):1960-1964. doi: 10.1002/anie.201810393. Epub 2019 Jan 17.

PMID:
30452103
44.

Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p.

Sievers P, Stichel D, Hielscher T, Schrimpf D, Reinhardt A, Wefers AK, Reuss D, Jones DTW, Bewerunge-Hudler M, Hartmann C, Baumgarten P, Wirsching HG, Winther-Kristensen B, Brokinkel B, Ketter R, Idoate Gastearena MA, Lamszus K, Seiz-Rosenhagen M, Mawrin C, Harter PN, Felsberg J, Hänggi D, Herold-Mende C, Berghoff AS, Weller M, Pfister SM, Wick W, Reifenberger G, Preusser M, von Deimling A, Sahm F.

Acta Neuropathol. 2018 Dec;136(6):975-978. doi: 10.1007/s00401-018-1924-x. Epub 2018 Oct 31. No abstract available.

PMID:
30382370
45.

Cognitive Aids for the Diagnosis and Treatment of Neuroanesthetic Emergencies: Consensus Guidelines on Behalf of the Society for Neuroscience in Anesthesiology and Critical Care (SNACC) Education Committee.

Hoefnagel AL, Rajan S, Martin A, Mahendra V, Knutson AK, Uejima JL, Kositratna G, Weller M, Yang H, Ahuja S, Bailey C, Bebawy JF.

J Neurosurg Anesthesiol. 2019 Jan;31(1):7-17. doi: 10.1097/ANA.0000000000000551.

PMID:
30334936
46.

Contraceptive drugs mitigate experimental stroke-induced brain injury.

El Amki M, Binder N, Steffen R, Schneider H, Luft AR, Weller M, Imthurn B, Merki-Feld GS, Wegener S.

Cardiovasc Res. 2019 Mar 1;115(3):637-646. doi: 10.1093/cvr/cvy248.

PMID:
30295757
47.

Women's knowledge about risk factors of breast cancer in a Brazilian community.

Freitas ÂGQ, Weller M.

Women Health. 2019 May-Jun;59(5):558-568. doi: 10.1080/03630242.2018.1516266. Epub 2018 Oct 4.

PMID:
30285565
48.

cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".

Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB, Kleinschmidt-DeMasters BK, Perry A, Reifenberger G, Stupp R, von Deimling A, Weller M.

Acta Neuropathol. 2018 Nov;136(5):805-810. doi: 10.1007/s00401-018-1913-0. Epub 2018 Sep 26. No abstract available.

PMID:
30259105
49.

Diagnosing and managing common genital emergencies in pediatric girls.

Arzubi-Hughes MK, Salts LA, Weller MA.

Pediatr Emerg Med Pract. 2018 Oct;15(10):1-23. Epub 2018 Oct 1.

PMID:
30251816
50.

Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma.

Thurner L, Preuss KD, Bewarder M, Kemele M, Fadle N, Regitz E, Altmeyer S, Schormann C, Poeschel V, Ziepert M, Walter S, Roth P, Weller M, Szczepanowski M, Klapper W, Monoranu C, Rosenwald A, Möller P, Hartmann S, Hansmann ML, Mackensen A, Schäfer H, Schorb E, Illerhaus G, Buslei R, Bohle RM, Stilgenbauer S, Kim YJ, Pfreundschuh M.

Blood. 2018 Dec 27;132(26):2744-2753. doi: 10.1182/blood-2018-03-836932. Epub 2018 Sep 24.

PMID:
30249786

Supplemental Content

Loading ...
Support Center